News Coverage 11.07.19 By: Arlene Weintraub Share on Twitter Share on Facebook Share on LinkedIn ASH: UPenn’s CRISPR-edited immune cells prove safe in small cancer study Related Announcement, Our Impact, Press Release PICI at ASCO: New Data. Big Impact. Top Honors. Announcement, Partner Highlight, Press Release New PICI Collaboration Bolsters Science-to-Market Edge Announcement, Partner Highlight, Press Release PICI, Immunai to Build Landmark Cancer Dataset
Announcement, Partner Highlight, Press Release New PICI Collaboration Bolsters Science-to-Market Edge